-
1
-
2
-
3
Supplementary Figure 5: Pathway analysis after treatment with KC and KCM serum in precursor cells
Foilsithe / Cruthaithe 2025Ábhair: -
4
Supplementary Figure 1: Activation of AD-MSCs and PSCs by Muc5ac
Foilsithe / Cruthaithe 2025Ábhair: -
5
Supplementary Figure 4: RNA-sequencing in the primary AD-MSCs, BM-MSCs, and PSCs after treatment with KC and KCM serum
Foilsithe / Cruthaithe 2025Ábhair: -
6
Supplementary Figure 6: Age-dependent differences in CAF activation
Foilsithe / Cruthaithe 2025Ábhair: -
7
Supplementary Figure 2: Pathway analysis in AD-MSCs and PSCs activated by Muc5ac
Foilsithe / Cruthaithe 2025Ábhair: -
8
-
9
-
10
-
11
-
12
-
13
-
14
-
15
-
16
-
17
Supplementary Data from <i>N</i><sup>6</sup>-methyladenosine Modification of FZR1 mRNA Promotes Gemcitabine Resistance in Pancreatic Cancer
Foilsithe / Cruthaithe 2025Ábhair: -
18
-
19
-
20